WEIYAO BEI-DINGMAN
Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Family GARLAND, TX NPI 1598074791
Browse related groups: Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Family TX Acerta Pharma LLC All categories
General Payments — all program years on this page
$97.19
- Category: General Payments
- Program years: PY2021
- Record count: 7
- As of (CMS publication): 2026-01-23
Latest program year (PY2021): $97.19 across 7 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2021) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $97.19 | 7 |
By paying entity
Latest program year (PY2021) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Acerta Pharma LLC | $35.39 | 3 |
| Lilly USA, LLC | $25.03 | 2 |
| Esperion Therapeutics, Inc. | $22.83 | 1 |
| Amgen Inc. | $13.94 | 1 |
By program year
| Program year | Amount | Records |
|---|---|---|
| 2021 | $97.19 | 7 |
Records — PY2021 (7)
| Record ID | Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Source |
|---|---|---|---|---|---|---|---|
| 819435989 | Lilly USA, LLC | $11.72 | 03/20/2021 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 819435991 | Lilly USA, LLC | $13.31 | 07/28/2021 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 826277619 | Amgen Inc. | $13.94 | 08/27/2021 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 829612743 | AstraZeneca Pharmaceuticals LP | $11.52 | 07/23/2021 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 829925015 | AstraZeneca Pharmaceuticals LP | $11.78 | 06/15/2021 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 830100773 | AstraZeneca Pharmaceuticals LP | $12.09 | 08/13/2021 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 838452381 | Esperion Therapeutics, Inc. | $22.83 | 08/17/2021 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2021_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.